MIR8054

Across TCGA pan-cancer cohorts, MIR8054 RNA is linked to patient survival in 7 of 34 cancer types, making it the most broadly survival-associated MIR8054 data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher MIR8054 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR8054 expression acts as an unfavorable survival marker.

BLCA, UCEC, and LIHC are the cancer types where MIR8054 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	OS	Tertile	All	0.082	0.688	<.001	90	view →
UCEC	DFS	Tertile	All	0.705	0.900	<.001	90	view →
LIHC	OS	Tertile	II,III,IV	0.051	0.716	<.001	72	view →
TGCT	OS	Tertile	All	0.869	0.968	.048	18	view →
HNSC	OS	Tertile	All	0.191	0.710	.021	18	view →
PCPG	DFS	Tertile	All	0.025	0.936	<.001	18	view →
STAD	DFS	Tertile	All	0.399	0.721	.007	9	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

MIR8054–BLCA (OS)

Open the BLCA breakdown →